§01 Browse › GHRP-2

GHRP-2

Growth Hormone Releasing Peptide-2
Research Compound
Growth hormone Recovery

This profile covers GHRP-2. Start with the peptide's intended use, human evidence and product-quality limitations before the mechanism details.

Technical catalog description

GHRP-2 is a synthetic hexapeptide that binds the growth-hormone secretagogue receptor (GHSR) to trigger robust pulses of growth hormone. It delivers larger peaks than earlier peptides but also noticeably stimulates appetite and can raise cortisol at higher doses.

When combined with a GHRH analogue such as CJC-1295, the pulse amplitude and duration increase dramatically, translating to superior muscle growth, fat-loss and recovery metrics.

Overview Use context Comparison Safety
Warning
Must be injected on empty stomach for optimal effect · Can cause increased hunger and appetite · May increase cortisol at higher doses

Read next

Overview

GHRP-2 is the stronger and rougher secretagogue option in this family. It produces a more obvious pulse than cleaner compounds such as Ipamorelin, but the cost is usually more hunger, more water retention, and more lifestyle friction around timing.

Unverified community timing claim: Existing descriptions favor empty-stomach administration. This catalog does not establish a validated meal-timing protocol.

Safety & monitoring
Side effects
  • Strong appetite increase, water retention, and possible cortisol drift

  • Injection-site irritation if handling is sloppy

Monitoring
  • fasting glucose if appetite and bodyweight trend upward

  • bodyweight and edema

Avoid if
  • Users with poor appetite control or already-worsening glucose tolerance

  • Anyone treating it as a replacement for sleep, diet, and training consistency

Use context

GHRP-2 is chosen by users who want a stronger secretagogue pulse and do not mind the appetite and cortisol tradeoff. It appeals to people willing to tolerate more mess in exchange for a bigger GH signal.

Timeline & expectations

Hunger and water retention usually show up before any meaningful body-composition story does. The longer-term payoff, if there is one, is better recovery and a modest body-composition push over time rather than a dramatic visual change in a week or two.

Common mistakes

Treating a community meal-timing claim as a verified protocol. Another mistake is combining multiple GH-related tools and assuming their individual effects can be identified.

Comparison notes

Compared with Ipamorelin, GHRP-2 is discussed as a stronger secretagogue. These comparisons do not establish an administration schedule.

Record quantities in the builder Read: Intro to Peptides ← Browse